6-pen-vasopressin compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514807, 530315, A61K 3734, C07K 716

Patent

active

047118776

ABSTRACT:
Vasopressin derivatives having unexpected VSP site binding activity whose structures are characterized by a Mpr unit at position 1 and a Pen unit at position 6 are prepared by standard peptide synthetic methods also using an oxidative cyclization of a linear peptide dimercaptan. A representative species is [1-.beta.-mercaptopropionic acid-2-(O-ethyl)-D-tyrosine-4-valine-6-penicillamine-8-arginine]vasopressi n.

REFERENCES:
patent: 3497491 (1970-02-01), Zaoral et al.
patent: 4367225 (1983-01-01), Manning et al.
patent: 4469679 (1984-09-01), Huffman et al.
patent: 4469680 (1984-09-01), Huffman et al.
patent: 4481194 (1984-11-01), Ali et al.
patent: 4482486 (1984-11-01), Brtnik et al.
patent: 4491577 (1985-01-01), Manning et al.
patent: 4508645 (1985-04-01), Simek et al.
Chem. Abstr., vol. 88 (1978), 676s.
F. L. Stassen et al., J. Pharmacology and Experimental Therapeutics, 223 53 (1982).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

6-pen-vasopressin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6-pen-vasopressin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-pen-vasopressin compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-22749

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.